Ori D. Rotstein
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ori D. Rotstein has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Mohammed Al-Omran
Department of Surgery, University of Toronto, Toronto, Canada
3 shared publications - Ben Li
Division of Vascular Surgery, St. Michael’s Hospital, Unity Health Toronto, University of Toronto, Toronto, ON M5B 1W8, Canada
2 shared publications - Charles de Mestral
University of Toronto
2 shared publications - Derek Beaton
University of Toronto
2 shared publications - Douglas S. Lee
University of Toronto
2 shared publications - Duminda Nalaka Wijeysundera
University of Toronto
2 shared publications
Latest Publications
- Open Access
- 4 March 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (5) , e039221
Using Machine Learning to Predict Outcomes Following Thoracic and Complex Endovascular Aortic Aneurysm Repair
Background: Thoracic endovascular aortic repair (TEVAR) and complex endovascular aneurysm repair (EVAR) are complex procedures that carry a significant risk of complications. While risk prediction tools can aid in clinical decision making, they remain limited. We developed machine learning algorithms to predict outcomes following TEVAR and complex EVAR. Methods: The Vascular Quality Initiative database was used to identify patients who underwent elective TEVAR and complex EVAR for noninfrarenal aortic aneurysms between 2012 and 2023. We extracted 172 features from the index hospitalization, including 93 preoperative (demographic/clinical), 46 intraoperative (procedural), and 33 postoperative (in‐hospital course/complications) variables. The primary outcome was 1‐year thoracoabdominal aortic aneurysm life‐altering event, defined as new permanent dialysis, new permanent paralysis, stroke, or death. The data were split into training (70%) and test (30%) sets. We trained 6 machine learning models using preoperative features with 10‐fold cross‐validation. Model robustness was evaluated using calibration plots and Brier scores. Results: Overall, 10 738 patients underwent TEVAR or complex EVAR, with 1485 (13.8%) experiencing 1‐year thoracoabdominal aortic aneurysm life‐altering event. Extreme Gradient Boosting was the best preoperative prediction model, achieving an area under the receiver operating characteristic curve of 0.96 (95% CI, 0.95–0.97), compared with 0.70 (95% CI, 0.68–0.72) for logistic regression. The Extreme Gradient Boosting model maintained excellent performance at the intra‐ and postoperative stages, with areas under the receiver operating characteristic curves of 0.97 (95% CI, 0.96–0.98) and 0.98 (95% CI, 0.97–0.99), respectively. Calibration plots indicated good agreement between predicted/observed event probabilities, with Brier scores of 0.09 (preoperative), 0.08 (intraoperative), and 0.05 (postoperative). Conclusions: Machine learning models can accurately predict 1‐year outcomes following TEVAR and complex EVAR, performing better than logistic regression.
- 4 March 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (5) , e039221
Open AccessUsing Machine Learning to Predict Outcomes Following Thoracic and Complex Endovascular Aortic Aneurysm Repair
Background: Thoracic endovascular aortic repair (TEVAR) and complex endovascular aneurysm repair (EVAR) are complex procedures that carry a significant risk of complications. While risk prediction tools can aid in clinical decision making, they remain limited. We developed machine learning algorithms to predict outcomes following TEVAR and complex EVAR. Methods: The Vascular Quality Initiative database was used to identify patients who underwent elective TEVAR and complex EVAR for noninfrarenal aortic aneurysms between 2012 and 2023. We extracted 172 features from the index hospitalization, including 93 preoperative (demographic/clinical), 46 intraoperative (procedural), and 33 postoperative (in‐hospital course/complications) variables. The primary outcome was 1‐year thoracoabdominal aortic aneurysm life‐altering event, defined as new permanent dialysis, new permanent paralysis, stroke, or death. The data were split into training (70%) and test (30%) sets. We trained 6 machine learning models using preoperative features with 10‐fold cross‐validation. Model robustness was evaluated using calibration plots and Brier scores. Results: Overall, 10 738 patients underwent TEVAR or complex EVAR, with 1485 (13.8%) experiencing 1‐year thoracoabdominal aortic aneurysm life‐altering event. Extreme Gradient Boosting was the best preoperative prediction model, achieving an area under the receiver operating characteristic curve of 0.96 (95% CI, 0.95–0.97), compared with 0.70 (95% CI, 0.68–0.72) for logistic regression. The Extreme Gradient Boosting model maintained excellent performance at the intra‐ and postoperative stages, with areas under the receiver operating characteristic curves of 0.97 (95% CI, 0.96–0.98) and 0.98 (95% CI, 0.97–0.99), respectively. Calibration plots indicated good agreement between predicted/observed event probabilities, with Brier scores of 0.09 (preoperative), 0.08 (intraoperative), and 0.05 (postoperative). Conclusions: Machine learning models can accurately predict 1‐year outcomes following TEVAR and complex EVAR, performing better than logistic regression.
- Open Access
- 3 September 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (17) , e035425
Using Machine Learning to Predict Outcomes Following Transfemoral Carotid Artery Stenting
Background: Transfemoral carotid artery stenting (TFCAS) carries important perioperative risks. Outcome prediction tools may help guide clinical decision‐making but remain limited. We developed machine learning algorithms that predict 1‐year stroke or death following TFCAS. Methods and Results: The VQI (Vascular Quality Initiative) database was used to identify patients who underwent TFCAS for carotid artery stenosis between 2005 and 2024. We identified 112 features from the index hospitalization (82 preoperative [demographic/clinical], 13 intraoperative [procedural], and 17 postoperative [in‐hospital course/complications]). The primary outcome was 1‐year postprocedural stroke or death. The data were divided into training (70%) and test (30%) sets. Six machine learning models were trained using preoperative features with 10‐fold cross‐validation. The primary model evaluation metric was area under the receiver operating characteristic curve. The algorithm with the best performance was further trained using intra‐ and postoperative features. Model robustness was assessed using calibration plots and Brier scores. Overall, 35 214 patients underwent TFCAS during the study period and 3257 (9.2%) developed 1‐year stroke or death. The best preoperative prediction model was extreme gradient boosting, achieving an area under the receiver operating characteristic curve of 0.94 (95% CI, 0.93–0.95). In comparison, logistic regression had an AUROC of 0.65 (95% CI, 0.63–0.67). The extreme gradient boosting model maintained excellent performance at the intra‐ and postoperative stages, with area under the receiver operating characteristic curve values of 0.94 (95% CI, 0.93–0.95) and 0.98 (95% CI, 0.97–0.99), respectively. Calibration plots showed good agreement between predicted/observed event probabilities with Brier scores of 0.11 (preoperative), 0.11 (intraoperative), and 0.09 (postoperative). Conclusions: Machine learning can accurately predict 1‐year stroke or death following TFCAS, performing better than logistic regression.
- 3 September 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (17) , e035425
Open AccessUsing Machine Learning to Predict Outcomes Following Transfemoral Carotid Artery Stenting
Background: Transfemoral carotid artery stenting (TFCAS) carries important perioperative risks. Outcome prediction tools may help guide clinical decision‐making but remain limited. We developed machine learning algorithms that predict 1‐year stroke or death following TFCAS. Methods and Results: The VQI (Vascular Quality Initiative) database was used to identify patients who underwent TFCAS for carotid artery stenosis between 2005 and 2024. We identified 112 features from the index hospitalization (82 preoperative [demographic/clinical], 13 intraoperative [procedural], and 17 postoperative [in‐hospital course/complications]). The primary outcome was 1‐year postprocedural stroke or death. The data were divided into training (70%) and test (30%) sets. Six machine learning models were trained using preoperative features with 10‐fold cross‐validation. The primary model evaluation metric was area under the receiver operating characteristic curve. The algorithm with the best performance was further trained using intra‐ and postoperative features. Model robustness was assessed using calibration plots and Brier scores. Overall, 35 214 patients underwent TFCAS during the study period and 3257 (9.2%) developed 1‐year stroke or death. The best preoperative prediction model was extreme gradient boosting, achieving an area under the receiver operating characteristic curve of 0.94 (95% CI, 0.93–0.95). In comparison, logistic regression had an AUROC of 0.65 (95% CI, 0.63–0.67). The extreme gradient boosting model maintained excellent performance at the intra‐ and postoperative stages, with area under the receiver operating characteristic curve values of 0.94 (95% CI, 0.93–0.95) and 0.98 (95% CI, 0.97–0.99), respectively. Calibration plots showed good agreement between predicted/observed event probabilities with Brier scores of 0.11 (preoperative), 0.11 (intraoperative), and 0.09 (postoperative). Conclusions: Machine learning can accurately predict 1‐year stroke or death following TFCAS, performing better than logistic regression.
- 6 July 2021
- Published by Springer Nature in Reviews in Endocrine and Metabolic Disorders
- Vol. 22 (4) , 1171-1188
Lessons from bariatric surgery: Can increased GLP-1 enhance vascular repair during cardiometabolic-based chronic disease?
Type 2 diabetes (T2D) and obesity represent entangled pandemics that accelerate the development of cardiovascular disease (CVD). Given the immense burden of CVD in society, non-invasive prevention and treatment strategies to promote cardiovascular health are desperately needed. During T2D and obesity, chronic dysglycemia and abnormal adiposity result in systemic oxidative stress and inflammation that deplete the vascular regenerative cell reservoir in the bone marrow that impairs blood vessel repair and exacerbates the penetrance of CVD co-morbidities. This novel translational paradigm, termed ‘regenerative cell exhaustion’ (RCE), can be detected as the depletion and dysfunction of hematopoietic and endothelial progenitor cell lineages in the peripheral blood of individuals with established T2D and/or obesity. The reversal of vascular RCE has been observed after administration of the sodium-glucose cotransporter-2 inhibitor (SGLT2i), empagliflozin, or after bariatric surgery for severe obesity. In this review, we explore emerging evidence that links improved dysglycemia to a reduction in systemic oxidative stress and recovery of circulating pro-vascular progenitor cell content required for blood vessel repair. Given that bariatric surgery consistently increases systemic glucagon-like-peptide 1 (GLP-1) release, we also focus on evidence that the use of GLP-1 receptor agonists (GLP-1RA) during obesity may act to inhibit the progression of systemic dysglycemia and adiposity, and indirectly reduce inflammation and oxidative stress, thereby limiting the impact of RCE. Therefore, therapeutic intervention with currently-available GLP-1RA may provide a less-invasive modality to reverse RCE, bolster vascular repair mechanisms, and improve cardiometabolic risk in individuals living with T2D and obesity.
- 6 July 2021
- Published by Springer Nature in Reviews in Endocrine and Metabolic Disorders
- Vol. 22 (4) , 1171-1188
Lessons from bariatric surgery: Can increased GLP-1 enhance vascular repair during cardiometabolic-based chronic disease?
Type 2 diabetes (T2D) and obesity represent entangled pandemics that accelerate the development of cardiovascular disease (CVD). Given the immense burden of CVD in society, non-invasive prevention and treatment strategies to promote cardiovascular health are desperately needed. During T2D and obesity, chronic dysglycemia and abnormal adiposity result in systemic oxidative stress and inflammation that deplete the vascular regenerative cell reservoir in the bone marrow that impairs blood vessel repair and exacerbates the penetrance of CVD co-morbidities. This novel translational paradigm, termed ‘regenerative cell exhaustion’ (RCE), can be detected as the depletion and dysfunction of hematopoietic and endothelial progenitor cell lineages in the peripheral blood of individuals with established T2D and/or obesity. The reversal of vascular RCE has been observed after administration of the sodium-glucose cotransporter-2 inhibitor (SGLT2i), empagliflozin, or after bariatric surgery for severe obesity. In this review, we explore emerging evidence that links improved dysglycemia to a reduction in systemic oxidative stress and recovery of circulating pro-vascular progenitor cell content required for blood vessel repair. Given that bariatric surgery consistently increases systemic glucagon-like-peptide 1 (GLP-1) release, we also focus on evidence that the use of GLP-1 receptor agonists (GLP-1RA) during obesity may act to inhibit the progression of systemic dysglycemia and adiposity, and indirectly reduce inflammation and oxidative stress, thereby limiting the impact of RCE. Therefore, therapeutic intervention with currently-available GLP-1RA may provide a less-invasive modality to reverse RCE, bolster vascular repair mechanisms, and improve cardiometabolic risk in individuals living with T2D and obesity.
- Open Access
- 1 August 2017
- Published by SAGE Publications in Surgical Infections
- Vol. 18 (6) , 659-663
Longer-Duration Antimicrobial Therapy Does Not Prevent Treatment Failure in High-Risk Patients with Complicated Intra-Abdominal Infections
Background: Recent studies have suggested the length of treatment of intra-abdominal infections (IAIs) can be shortened without detrimental effects on patient outcomes. However, data from high-risk patient populations are lacking. We hypothesized that patients at high risk for treatment failure will benefit from a longer course of antimicrobial therapy. Methods: Patients enrolled in the Study to Optimize Peritoneal Infection Therapy (STOP-IT) trial were evaluated retrospectively to identify risk factors associated with treatment failure, which was defined as the composite outcome of recurrent IAI, surgical site infection, or death. Variables were considered risk factors if there was a positive statistical association with treatment failure. Patients were then stratified according to the presence and number of these risk factors. Univariable analyses were performed using the Kruskal-Wallis, χ2, and Fisher exact tests. Logistic regression controlling for risk factors and original randomization group, either a fixed four-day antimicrobial regimen (experimental) or a longer course based on clinical response (control), also was performed. Results: We identified corticosteroid use, Acute Physiology and Chronic Health Evaluation II score ≥5, hospital-acquired infection, or a colonic source of IAI as risk factors associated with treatment failure. Of the 517 patients enrolled, 263 (50.9%) had one or two risk factors and 16 (3.1%) had three or four risk factors. The rate of treatment failure rose as the number of risk factors increased. When controlling for randomization group, the presence and number of risk factors were independently associated with treatment failure, but the duration of antimicrobial therapy was not. Conclusions: We were able to identify patients at high risk for treatment failure in the STOP-IT trial. Such patients did not benefit from a longer course of antibiotic administration. Further study is needed to determine the optimum duration of antimicrobial therapy in high-risk patients.
- 1 August 2017
- Published by SAGE Publications in Surgical Infections
- Vol. 18 (6) , 659-663
Open AccessLonger-Duration Antimicrobial Therapy Does Not Prevent Treatment Failure in High-Risk Patients with Complicated Intra-Abdominal Infections
Background: Recent studies have suggested the length of treatment of intra-abdominal infections (IAIs) can be shortened without detrimental effects on patient outcomes. However, data from high-risk patient populations are lacking. We hypothesized that patients at high risk for treatment failure will benefit from a longer course of antimicrobial therapy. Methods: Patients enrolled in the Study to Optimize Peritoneal Infection Therapy (STOP-IT) trial were evaluated retrospectively to identify risk factors associated with treatment failure, which was defined as the composite outcome of recurrent IAI, surgical site infection, or death. Variables were considered risk factors if there was a positive statistical association with treatment failure. Patients were then stratified according to the presence and number of these risk factors. Univariable analyses were performed using the Kruskal-Wallis, χ2, and Fisher exact tests. Logistic regression controlling for risk factors and original randomization group, either a fixed four-day antimicrobial regimen (experimental) or a longer course based on clinical response (control), also was performed. Results: We identified corticosteroid use, Acute Physiology and Chronic Health Evaluation II score ≥5, hospital-acquired infection, or a colonic source of IAI as risk factors associated with treatment failure. Of the 517 patients enrolled, 263 (50.9%) had one or two risk factors and 16 (3.1%) had three or four risk factors. The rate of treatment failure rose as the number of risk factors increased. When controlling for randomization group, the presence and number of risk factors were independently associated with treatment failure, but the duration of antimicrobial therapy was not. Conclusions: We were able to identify patients at high risk for treatment failure in the STOP-IT trial. Such patients did not benefit from a longer course of antibiotic administration. Further study is needed to determine the optimum duration of antimicrobial therapy in high-risk patients.
- Open Access
- 1 November 2016
- Published by SAGE Publications in Surgical Infections Case Reports
- Vol. 1 (1) , 135-138
De Garengeot Hernia: A Case of Incarcerated Femoral Hernia Containing the Appendix
Background: De Garengeot hernias are defined by the presence of the vermiform appendix within a femoral hernia. The incidence of such hernias is low and their pre-operative diagnosis is challenging. Case Presentation: An 85-year-old Caucasian female presented to the hospital with three-day history of tender and erythematous inguinal mass. A computed tomography (CT) scan of the area showed a hernia sac containing a tubular structure resembling the appendix. The patient was taken to the operating room for exploration of the inguinal mass with the goal of managing the hernia and its contents. At surgery, the diagnosis of a De Garengeot hernia was made. Here we discuss the diagnostic and surgical approaches to treating this patient. Conclusion: The majority of De Garengeot hernias present in the context of incarcerated femoral hernia. The pre-operative diagnosis of this type of hernia is challenging and CT imaging is the most effective modality to make the diagnosis.
- 1 November 2016
- Published by SAGE Publications in Surgical Infections Case Reports
- Vol. 1 (1) , 135-138
Open AccessDe Garengeot Hernia: A Case of Incarcerated Femoral Hernia Containing the Appendix
Background: De Garengeot hernias are defined by the presence of the vermiform appendix within a femoral hernia. The incidence of such hernias is low and their pre-operative diagnosis is challenging. Case Presentation: An 85-year-old Caucasian female presented to the hospital with three-day history of tender and erythematous inguinal mass. A computed tomography (CT) scan of the area showed a hernia sac containing a tubular structure resembling the appendix. The patient was taken to the operating room for exploration of the inguinal mass with the goal of managing the hernia and its contents. At surgery, the diagnosis of a De Garengeot hernia was made. Here we discuss the diagnostic and surgical approaches to treating this patient. Conclusion: The majority of De Garengeot hernias present in the context of incarcerated femoral hernia. The pre-operative diagnosis of this type of hernia is challenging and CT imaging is the most effective modality to make the diagnosis.
- 7 October 2010
- Published by Springer Nature in Surgical Endoscopy
- Vol. 25 (3) , 930-934
“No scar” small bowel resection in a survival porcine model using transcolonic NOTES® and transabdominal approach
Fundamental techniques and essential tools for performing “no scar” surgery still need to be developed. Our study was designed to evaluate the feasibility of performing small bowel resection by transcolonic NOTES® and transabdominal approach using rigid laparoscopic and flexible endoscopic instruments. One non survival and four survival experiments were performed using a porcine model. The endoscope with an overtube was advanced into the peritoneal cavity through the colotomy. Mini-laparoscopic instruments were placed through the abdominal wall under the endoscopic observation. The endoscope was replaced with a rigid linear stapler. The small bowel was identified. The segment of the small bowel was resected by firing the endo stapler, and extracted through the colon. The two limbs of the small bowel were approximated with two stay-sutures. An enterotomy was then created on the antimesenteric sides of each line. A side-to-side anastomosis was performed with another application of the endo stapler. The stapler was withdrawn. The enterotomy was closed by suturing. The colotomy was closed with endoclips and the endoscope was withdrawn. The mini-laparoscopic instruments were removed. Small bowel resection was successfully performed in all animals. The surgery time was 70 minutes. There was no mortality or complications. The animals recovered uneventfully, and survived the 2 weeks postprocedure period. They remained healthy, and gained weight. Necropsy was performed 2 weeks after the surgery. On necropsy, evaluation of the abdominal skin revealed no scars. The peritoneal cavity was examined. No signs of infection, bleeding, perforations, and adhesions were noted. Endoscopic examination of the colotomy and anastomosis revealed complete healing that was confirmed by histopathology. The study has demonstrated the feasibility of small bowel resection using transcolonic NOTES® and transabdominal approach. Simultaneous use of flexible endoscopic and rigid laparoscopic instruments in NOTES® is not only feasible but has significant advantages and greatly facilitates the performance of the operation, yet leaves no scars.
- 7 October 2010
- Published by Springer Nature in Surgical Endoscopy
- Vol. 25 (3) , 930-934
“No scar” small bowel resection in a survival porcine model using transcolonic NOTES® and transabdominal approach
Fundamental techniques and essential tools for performing “no scar” surgery still need to be developed. Our study was designed to evaluate the feasibility of performing small bowel resection by transcolonic NOTES® and transabdominal approach using rigid laparoscopic and flexible endoscopic instruments. One non survival and four survival experiments were performed using a porcine model. The endoscope with an overtube was advanced into the peritoneal cavity through the colotomy. Mini-laparoscopic instruments were placed through the abdominal wall under the endoscopic observation. The endoscope was replaced with a rigid linear stapler. The small bowel was identified. The segment of the small bowel was resected by firing the endo stapler, and extracted through the colon. The two limbs of the small bowel were approximated with two stay-sutures. An enterotomy was then created on the antimesenteric sides of each line. A side-to-side anastomosis was performed with another application of the endo stapler. The stapler was withdrawn. The enterotomy was closed by suturing. The colotomy was closed with endoclips and the endoscope was withdrawn. The mini-laparoscopic instruments were removed. Small bowel resection was successfully performed in all animals. The surgery time was 70 minutes. There was no mortality or complications. The animals recovered uneventfully, and survived the 2 weeks postprocedure period. They remained healthy, and gained weight. Necropsy was performed 2 weeks after the surgery. On necropsy, evaluation of the abdominal skin revealed no scars. The peritoneal cavity was examined. No signs of infection, bleeding, perforations, and adhesions were noted. Endoscopic examination of the colotomy and anastomosis revealed complete healing that was confirmed by histopathology. The study has demonstrated the feasibility of small bowel resection using transcolonic NOTES® and transabdominal approach. Simultaneous use of flexible endoscopic and rigid laparoscopic instruments in NOTES® is not only feasible but has significant advantages and greatly facilitates the performance of the operation, yet leaves no scars.